Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × Disulfides × Clear all

NCT04605731 2025-09-10

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

Phase 1 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular